The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
127095211 12709521 1 I 20160829 20160902 20160902 EXP JP-MYLANLABS-2016M1037166 MYLAN ISHII S, UEDA T, HIGUCHI M, MIMA T, YAKUSHIJI N. COMBINATION CHEMOTHERAPY OF S-1, DOCETAXEL AND CDDP PRODUCES A REMARKABLE RESPONSE IN A PATIENT WITH METASTASES OF SUPRACLAVICULAR LYMPH NODES AND GINGIVAL CARCINOMA OF THE MANDIBLE. GAN-TO-KAGAKU-RYOHO 2010;37(9):1763-1765. 0.00 Y 0.00000 20160902 OT JP JP

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
127095211 12709521 1 PS CISPLATIN. CISPLATIN 1 Unknown 10MG/M2 ON DAYS 1 AND 8 FOLLOWED BY AT LEAST 7 DAYS OF WITHDRAWAL U U 91062
127095211 12709521 2 SS DOCETAXEL. DOCETAXEL 1 Unknown 35MG/M2 ON DAYS 1 AND 8 FOLLOWED BY AT LEAST 7 DAYS OF WITHDRAWAL U U 0
127095211 12709521 3 SS GIMERACIL W/OTERACIL POTASSIUM/TEGAFUR GIMERACILOTERACILTEGAFUR 1 Unknown 80MG ON DAYS 1-14 FOLLOWED BY AT LEAST 7 DAYS OF WITHDRAWAL U U 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
127095211 12709521 1 Metastatic squamous cell carcinoma
127095211 12709521 2 Metastatic squamous cell carcinoma
127095211 12709521 3 Metastatic squamous cell carcinoma

Outcome of event

Event ID CASEID OUTC COD
127095211 12709521 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
127095211 12709521 Alopecia
127095211 12709521 Diarrhoea
127095211 12709521 Mucosal inflammation
127095211 12709521 Neutropenia

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
127095211 12709521 1 20071010 0
127095211 12709521 2 20071010 0
127095211 12709521 3 20071010 0